AMARIN CORP PLC\UK

AMRN

AMARIN CORP PLC\UK

AMRN

Insider Sentiment (TTM):

Last Purchase:2024-08-02Last Sale:2023-12-12Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:N/AInstitutional Shares Owned:N/AShares Outstanding:N/AInstitutional Ownership Pct.:N/A

Earnings Market Reaction:

Filing Date:2026-04-29Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	131	135	123	148	120	121	157	216	214	199	271	233
Restricted Cash And Cash Equivalents At Carrying V…	0	0	0	0	0	0	1	1	1	1	1	1
Short Term Investments	177	168	164	151	162	173	149	91	94	121	50	80
Accounts Receivable Net Current	108	127	127	119	107	122	113	124	116	134	122	123
Inventory Net	184	196	185	171	159	166	224	239	255	259	254	227
Prepaid Expense And Other Assets Current	26	24	29	17	25	13	7	32	8	12	19	43
Assets Current	626	650	628	607	573	595	650	702	688	725	718	706
Property Plant And Equipment Net	-	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	0
Inventory Noncurrent	-	0	9	40	57	65	74	71	74	78	92	122
Operating Lease Right Of Use Asset	6	6	7	8	8	8	8	8	8	8	9	9
Other Assets Noncurrent	1	1	1	1	1	1	1	1	1	1	1	2
Finite Lived Intangible Assets Net	13	13	14	15	16	16	17	18	19	19	20	20
Assets	646	671	660	670	656	685	751	800	790	832	839	860
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	48	45	37	45	46	40	41	54	68	53	53	54
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	2	2	2	2
Liabilities Current	180	194	182	186	162	180	202	231	224	259	267	271
Liabilities Noncurrent
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	2	3	3	3
Operating Lease Liability Noncurrent	6	6	7	7	8	8	8	8	8	9	9	9
Other Liabilities Noncurrent	11	11	12	12	12	12	9	9	9	9	7	7
Liabilities	196	211	201	205	182	199	219	248	244	280	286	291
Stockholders Equity
Common Stock Value	314	310	310	309	308	305	305	305	305	303	302	302
Additional Paid In Capital	1,922	1,924	1,922	1,921	1,916	1,915	1,911	1,907	1,903	1,899	1,895	1,892
Treasury Stock Value	-69	-67	-67	-67	-66	-65	-65	-65	-65	-64	-64	-63
Retained Earnings Accumulated Deficit	-1,718	-1,707	-1,706	-1,698	-1,684	-1,669	-1,620	-1,595	-1,596	-1,586	-1,581	-1,561
Stockholders Equity	449	459	459	465	474	486	531	552	546	552	553	569
Liabilities And Stockholders Equity	646	671	660	670	656	685	751	800	790	832	839	860
Common Stock Par Or Stated Value Per Share	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5
Common Stock Shares Issued	22	21	21	21	21	21	21	21	21	21	21	21
Shares Outstanding	21	21	21	21	21	21	21	21	21	20	20	20
Treasury Stock Common Shares	1	1	1	1	1	1	1	1	1	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	0.98%	12.18%	-2.45%	-	-	-	-	-	-	-	-	-
2025	13.85%	54.32%	51.18%	6.75%	2.54%	31.20%	-2.56%	-17.91%	-12.08%	3.73%	2.73%	3.59%
2024	1.19%	-17.86%	-7.14%	-7.35%	-13.24%	-14.71%	-8.33%	-23.33%	-6.67%	0.00%	36.37%	44.88%
2023	-12.50%	-16.18%	-17.65%	-15.13%	-21.85%	-36.97%	11.43%	30.00%	50.00%	-19.63%	-19.63%	-18.69%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.48	3.34	3.45	3.26	3.53	3.31	3.23	3.04	3.07	2.80	2.69	2.61
Quick Ratio	2.32	2.21	2.27	2.25	2.39	2.32	2.08	1.87	1.89	1.75	1.66	1.61
Working Capital	446.37M	455.42M	446.10M	420.87M	410.65M	415.45M	448.66M	471.30M	463.55M	465.70M	450.82M	435.56M
Leverage & Debt
Debt to Equity	0.44	0.46	0.44	0.44	0.38	0.41	0.41	0.45	0.45	0.51	0.52	0.51
Interest Coverage TTM	-5.72	-6.06	-11.65	-12.46	-9.98	-9.15	-4.40	-4.09	-6.65	-8.01	-8.57	-9.38
Debt Ratio	0.30	0.32	0.30	0.31	0.28	0.29	0.29	0.31	0.31	0.34	0.34	0.34
Efficiency & Turnover
Asset Turnover TTM	0.33	0.32	0.32	0.30	0.30	0.30	0.30	0.32	0.34	0.36	0.37	0.38
Days Sales Outstanding TTM	180.84	212.79	193.14	202.02	189.68	204.24	177.97	169.85	163.81	157.31	139.11	140.55
Receivables Turnover TTM	2.02	1.72	1.89	1.81	1.92	1.79	2.05	2.15	2.23	2.32	2.62	2.60
Per Share Metrics
Diluted EPS TTM	-1.60	-1.87	-4.15	-5.00	-4.25	-4.00	-1.91	-1.63	-2.57	-2.90	-2.57	-1.88
Free Cash Flow Per Share TTM	1.22	0.32	-1.05	-0.56	-1.49	-1.51	-0.89	-0.42	0.06	0.34	0.44	-0.81
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	52.37%	56.57%	38.87%	37.47%	34.85%	35.60%	56.46%	56.51%	53.89%	53.94%	57.07%	62.69%
Operating Profit Margin TTM	-20.64%	-23.48%	-42.50%	-50.34%	-44.35%	-40.15%	-18.30%	-15.26%	-23.01%	-22.02%	-22.43%	-16.18%
Net Profit Margin TTM	-15.51%	-18.16%	-38.01%	-47.22%	-41.07%	-35.95%	-16.32%	-12.66%	-18.96%	-19.26%	-16.27%	-11.06%
Growth Metrics
Net Revenue Growth (1Y)	1.24%	-6.55%	-5.93%	-17.15%	-22.83%	-25.51%	-25.25%	-23.53%	-23.04%	-16.87%	-23.85%	-27.19%
Net Income Growth (1Y)	-61.77%	-52.79%	119.06%	209.01%	67.15%	39.03%	-25.02%	-12.48%	-42.00%	-44.13%	-42.94%	-61.69%
EPS Growth (1Y)	-62.29%	-53.25%	116.75%	206.30%	65.82%	37.92%	-25.52%	-13.12%	-42.56%	-45.02%	-43.47%	-62.59%
Valuation Metrics
P/E TTM	-9.01	-7.47	-3.95	-3.24	-2.12	-2.45	-6.58	-8.46	-6.94	-6.00	-7.16	-12.67
P/B TTM	0.67	0.63	0.74	0.72	0.39	0.41	0.49	0.51	0.67	0.64	0.68	0.85
P/S TTM	1.40	1.36	1.50	1.53	0.87	0.88	1.07	1.07	1.32	1.16	1.17	1.40
Market Cap	302.98M	289.66M	340.32M	336.14M	186.04M	201.36M	259.02M	283.49M	365.03M	354.66M	375.74M	485.34M
Enterprise Value	171.91M	155.00M	217.52M	188.26M	66.52M	80.32M	102.08M	67.56M	151.09M	155.41M	104.93M	252.34M
Calculated Values
Free Cash Flow TTM	25.58M	6.73M	-21.86M	-11.52M	-30.88M	-31.02M	-18.36M	-8.67M	1.29M	6.88M	9.08M	-16.47M
Net Debt	-131.06M	-134.66M	-122.80M	-147.88M	-119.52M	-121.04M	-156.94M	-215.92M	-213.94M	-199.25M	-270.81M	-233.00M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-08-02Purchase

Owner: Berg, Aaron

Title: President and CEO

Shares: 160,000

Price/Share: $0.64

Value: $102,400.00

Shares Owned: 805,380

Relationship: Officer

Ownership: Direct

2024-01-22Purchase

Owner: Holt, Patrick

Title: President and CEO

Shares: 14,426

Price/Share: $1.09

Value: $15,724.34

Shares Owned: 314,426

Relationship: Director,Officer

Ownership: Direct

2023-12-12Sale

Owner: Ketchum, Steven B

Title: Chief Scientific Officer

Shares: 34,131

Price/Share: $0.79

Value: $26,963.49

Shares Owned: 566,100

Relationship: Officer

Ownership: Direct

2023-08-16Purchase

Owner: Holt, Patrick

Title: President and CEO

Shares: 300,000

Price/Share: $1.04

Value: $312,000.00

Shares Owned: 300,000

Relationship: Director,Officer

Ownership: Direct

2022-06-13Purchase

Owner: Wold, Olsen Per

Title: -

Shares: 55,000

Price/Share: $1.69

Value: $92,950.00

Shares Owned: 149,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-08-02	Berg, Aaron	Officer	President and CEO	Direct	Purchase	160,000	0.64	$102,400.00	805,380	4
2024-01-22	Holt, Patrick	Director,Officer	President and CEO	Direct	Purchase	14,426	1.09	$15,724.34	314,426	4
2023-12-12	Ketchum, Steven B	Officer	Chief Scientific Officer	Direct	Sale	34,131	0.79	$26,963.49	566,100	4
2023-08-16	Holt, Patrick	Director,Officer	President and CEO	Direct	Purchase	300,000	1.04	$312,000.00	300,000	4
2022-06-13	Wold, Olsen Per	Director	-	Direct	Purchase	55,000	1.69	$92,950.00	149,000	4
2021-12-14	Zakrzewski, Joseph S	Director	-	Direct	Purchase	10,000	3.27	$32,700.00	194,547	4
2021-08-12	Kalb, Michael Wayne	Officer	SVP and CFO	Direct	Sale	120,000	5.25	$630,000.00	205,010	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No institutional ownership data available.

AMARIN CORP PLC\UK (AMRN) — SEC Financial Statements & Analysis

AMARIN CORP PLC\UK (AMRN) is a pharmaceutical preparations company, incorporated in X0. AMARIN CORP PLC\UK trades on AMRN: Nasdaq as: AMRN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), AMARIN CORP PLC\UK reported a 1.24% year-over-year revenue growth, a Gross Profit Margin of 52.37% (TTM), a Debt-to-Equity ratio of 0.44x, a Price-to-Sales (P/S) ratio of 1.40x (TTM), a Price-to-Book (P/B) ratio of 0.67 (TTM), at a market cap of $302.98M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 1.24%
Gross Profit Margin TTM: 52.37%
Debt To Equity: 0.44x
P/S TTM: 1.40x
P/B TTM: 0.67
Market Cap: $302.98M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is AMARIN CORP PLC\UK in?

AMARIN CORP PLC\UK (AMRN) operates in the Pharmaceutical Preparations industry.

What is AMRN's market cap?

AMARIN CORP PLC\UK (AMRN) has a market capitalization of $302.98M as of 2026-03-31.

What exchange does AMRN trade on?

AMARIN CORP PLC\UK (AMRN) trades on the AMRN: Nasdaq.

Where is AMARIN CORP PLC\UK incorporated?

AMARIN CORP PLC\UK is incorporated in United Kingdom.

AMARIN CORP PLC\UK (AMRN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.